At-Risk Variant in TCF7L2 for Type II Diabetes Increases Risk of Schizophrenia

被引：107

作者：

Hansen, Thomas ^{[1
,2
]}

Ingason, Andres ^{[1
]}

Djurovic, Srdjan ^{[3
]}

Melle, Ingrid ^{[3
,4
]}

Fenger, Mogens ^{[5
]}

Gustafsson, Omar ^{[6
]}

Jakobsen, Klaus D. ^{[1
,2
,7
]}

Rasmussen, Henrik B. ^{[1
]}

Tosato, Sarah ^{[8
]}

Rietschel, Marcella ^{[9
]}

Frank, Josef ^{[9
]}

Owen, Mike ^{[10
]}

Bonetto, Chiara ^{[8
]}

Suvisaari, Jaana ^{[11
,12
,13
]}

Thygesen, Johan Hilge ^{[1
]}

Petursson, Hannes ^{[14
]}

Lonnqvist, Jouko ^{[11
,12
,13
]}

Sigurdsson, Engilbert ^{[14
]}

Giegling, Ina ^{[15
]}

Craddock, Nick ^{[10
]}

O'Donovan, Michael C. ^{[10
]}

Ruggeri, Mirella ^{[8
]}

Cichon, Sven ^{[16
,17
]}

Ophoff, Roel A. ^{[18
,19
,20
]}

Pietilainen, Olli ^{[11
,12
,13
]}

Peltonen, Leena ^{[11
,12
,13
,21
,22
,23
]}

Noethen, Markus M. ^{[24
]}

Rujescu, Dan ^{[15
]}

St Clair, David ^{[25
]}

Collier, David A. ^{[26
]}

Andreassen, Ole A. ^{[4
,6
]}

Werge, Thomas ^{[1
]}

机构：

[1] Copenhagen Univ Hosp, Res Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, Boserupvej 4, DK-4000 Roskilde, Denmark

[2] Univ Copenhagen, Ctr Pharmacogenom, Copenhagen, Denmark

[3] Univ Oslo, Oslo Univ Hosp Ulleval, Dept Med Genet, Oslo, Norway

[4] Univ Oslo, Inst Psychiat, TOP Project, Oslo, Norway

[5] Copenhagen Univ Hosp, Dept Clin Biochem, Hvidovre, Denmark

[6] Oslo Univ Hosp Ulleval, Dept Psychiat, Oslo, Norway

[7] Copenhagen Univ Hosp, Psychiat Ctr Hvidovre, Hvidovre, Denmark

[8] Univ Verona, Sect Psychiat & Clin Psychol, Dept Publ Hlth & Community Med, I-37100 Verona, Italy

[9] Univ Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany

[10] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff, S Glam, Wales

[11] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland

[12] Univ Helsinki, Natl Inst Hlth & Welf, Helsinki, Finland

[13] Univ Helsinki, Dept Med Genet, Helsinki, Finland

[14] Natl Univ Hosp Reykjavik, Dept Psychiat, Reykjavik, Iceland

[15] Univ Munich, Div Mol & Clin Neurol, Munich, Germany

[16] Forschungszentrum Julich, Inst Neurosci & Med, D-52425 Julich, Germany

[17] Univ Bonn, Life & Brain Ctr, Dept Genom, D-5300 Bonn, Germany

[18] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands

[19] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands

[20] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA USA

[21] Wellcome Trust Sanger Inst, Cambridge, England

[22] Harvard Univ, Broad Inst, Boston, MA 02115 USA

[23] MIT, Boston, MA USA

[24] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany

[25] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland

[26] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychol Ctr, London WC2R 2LS, England

来源：

BIOLOGICAL PSYCHIATRY | 2011年 / 70卷 / 01期

基金：

英国医学研究理事会;

关键词：

Diabetes type II; genetic risk variants; rs7903146; schizophrenia; TCF7L2; GENOME-WIDE ASSOCIATION; DRUG-NAIVE PATIENTS; GLUCOSE-TOLERANCE; DEMENTIA-PRAECOX; BLOOD-SUGAR; GENE; LOCI; MELLITUS; INSULIN; IMMUNOREACTIVITY;

D O I：

10.1016/j.biopsych.2011.01.031

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Background: Schizophrenia is associated with increased risk of type II diabetes and metabolic disorders. However, it is unclear whether this comorbidity reflects shared genetic risk factors, at-risk lifestyle, or side effects of antipsychotic medication. Methods: Eleven known risk variants of type II diabetes were genotyped in patients with schizophrenia in a sample of 410 Danish patients, each matched with two healthy control subjects on sex, birth year, and month. Replication was carried out in a large multinational European sample of 4089 patients with schizophrenia and 17,597 controls (SGENE+) using Mantel-Haenszel test. Results: One type II diabetes at-risk allele located in TCF7L2, rs7903146 [T], was associated with schizophrenia in the discovery sample (p = .0052) and in the replication with an odds ratio of 1.07 (95% confidence interval 1.01-1.14, p = .033). Conclusion: The association reported here with a well-known diabetes variant suggests that the observed comorbidity is partially caused by genetic risk variants. This study also demonstrates how genetic studies can successfully examine an epidemiologically derived hypothesis of comorbidity.

引用

页码：59 / 63

页数：5

共 50 条

[31] Association of the Type 2 Diabetes Mellitus Susceptibility Gene, TCF7L2, with Schizophrenia in an Arab-Israeli Family Sample
Alkelai, Anna
Greenbaum, Lior
Lupoli, Sara
Kohn, Yoav
Sarner-Kanyas, Kyra
Ben-Asher, Edna
Lancet, Doron
Macciardi, Fabio
Lerer, Bernard
PLOS ONE, 2012, 7 (01):
[32] The Role of Wnt3a/β-Catenin/TCF7L2 Pathway in Diabetes and Cardiorenal Complications
Adeerjiang, Yilinuer
Sidike, Abudulimu
Gan, Xiao-Xue
Li, Qin-Tian
Jiang, Sheng
CARDIORENAL MEDICINE, 2025, 15 (01) : 72 - 82
[33] TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy
Ciccacci, Cinzia
Di Fusco, Davide
Cacciotti, Laura
Morganti, Roberto
D'Amato, Cinzia
Novelli, Giuseppe
Sangiuolo, Federica
Spallone, Vincenza
Borgiani, Paola
ACTA DIABETOLOGICA, 2013, 50 (05) : 789 - 799
[34] TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes
Redondo, Maria J.
Geyer, Susan
Steck, Andrea K.
Sosenko, Jay
Anderson, Mark
Antinozzi, Peter
Michels, Aaron
Wentworth, John
Xu, Ping
Pugliese, Alberto
DIABETES CARE, 2018, 41 (02) : 311 - 317
[35] Genetic variants of TCF7L2 are associated with type 2 diabetes in a northeastern Chinese population
Qiao, Hong
Zhang, Xuelong
Zhao, Xuedan
Zhao, Yanling
Xu, Lidan
Sun, Haiming
Fu, Songbin
GENE, 2012, 495 (02) : 115 - 119
[36] Effect of TCF7L2 polymorphism on pancreatic hormones after exenatide in type 2 diabetes
Mari Cassol Ferreira
Maria Elizabeth Rossi da Silva
Rosa Tsuneshiro Fukui
Maria do Carmo Arruda-Marques
Salman Azhar
Rosa Ferreira dos Santos
Diabetology & Metabolic Syndrome, 11
[37] The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5
Xia, Qianghua
Chesi, Alessandra
Manduchi, Elisabetta
Johnston, Brian T.
Lu, Sumei
Leonard, Michelle E.
Parlin, UrsulaW.
Rappaport, Eric F.
Huang, Peng
Wells, Andrew D.
Blobel, Gerd A.
Johnson, Matthew E.
Grant, Struan F. A.
DIABETOLOGIA, 2016, 59 (11) : 2360 - 2368
[38] Investigation of Type 2 Diabetes Risk Alleles Support CDKN2A/B, CDKAL1, and TCF7L2 As Susceptibility Genes in a Han Chinese Cohort
Wen, Jie
Ronn, Tina
Olsson, Anders
Yang, Zhen
Lu, Bin
Du, Yieping
Groop, Leif
Ling, Charlotte
Hu, Renming
PLOS ONE, 2010, 5 (02):
[39] Transcription Factor 7-Like 2 (TCF7L2) Polymorphism and Context-Specific Risk of Type 2 Diabetes in African American and Caucasian Adults The Atherosclerosis Risk in Communities Study
Yan, Yu
North, Kari E.
Ballantyne, Christie M.
Brancati, Frederick L.
Chambless, Lloyd E.
Franceschini, Nora
Heiss, Gerardo
Kottgen, Anna
Pankow, James S.
Selvin, Elizabeth
West, Suzanne L.
Boerwinkle, Eric
DIABETES, 2009, 58 (01) : 285 - 289
[40] Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia
Kristensen, Peter L.
Pedersen-Bjergaard, Ulrik
Due-Andersen, Rikke
Hoi-Hansen, Thomas
Grimmeshave, Lise
Lyssenko, Valeriya
Groop, Leif
Holst, Jens J.
Vaag, Allan A.
Thorsteinsson, Birger
ENDOCRINE CONNECTIONS, 2016, 5 (06): : 53 - 60

← 1 2 3 4 5 →